Published

Psychedelic drug psilocybin shows promise treating anorexia in early trials

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: The New Scientist
Date: 2023-06-30
Source: OpenAlex
DOI: 10.1016/s0262-4079(23)01394-5
PubMed: Unavailable

Authors

Grace Wade

Watch author

Topics and keywords

psilocybin Eating Disorders Clinical Trial Clinical Trial Psilocybin Anorexia Drug trial Hallucinogen Drug Psychology Psychotherapist Psychiatry Medicine Psychoanalysis Clinical trial Internal medicine Psychedelics and Drug Studies Digital Mental Health Interventions

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelic drug psilocybin shows promise treating anorexia in early trials2023-06-30

Related papers

6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the ResearchJournal of the American Academy of Child & Adolescent Psychiatry · 2023-09-30 Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility StudyFOCUS The Journal of Lifelong Learning in Psychiatry · 2024-06-30 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-03-05 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16